Donanemab Antibody
Donanemab is a humanized monoclonal antibody targeting amyloid-beta plaques for early Alzheimer's disease research. It has demonstrated efficacy in reducing amyloid and tau pathology in clinical trials, supporting its investigation in both in vitro and in vivo models of neurodegenerative disease.
Product Specifications
Product Name Alternative
Tau, βAmyloid, β Amyloid, LY3002813, Microtubule Associated, MicrotubuleAssociated, Beta Amyloid, BetaAmyloid, Aβ, b Amyloid, bAmyloid
Target
Beta Amyloid, Microtubule Associated
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience, Signal Transduction
Concentration
5.54 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.36 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PE-Linked Polyclonal Antibody to Cytochrome P450 2E1 (CYP2E1)
PE-Linked Polyclonal Antibody to Cytochrome P450 2E1 (CYP2E1)
PE-Linked Polyclonal Antibody to Cytochrome P450 2E1 (CYP2E1)
PE-Linked Polyclonal Antibody to Cytochrome P450 2E1 (CYP2E1)